One-year results from the EnligHTN 1
trial of St. Jude Medical Inc.’s EnligHTN multi-electrode renal denervation system and interim data from the REDUCE-HTN
EuroPCR in Brief
New clinical data from St. Jude Medical’s and Boston Scientific’s trials of renal denervation devices to treat hypertension show progress in the development of these novel blood pressure therapies, but both companies remain behind Medtronic. More news from EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions.